DRTS (Alpha Tau Medical) Net Income From Continuing Operations : $-32.46 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Alpha Tau Medical's net income from continuing operations for the three months ended in Mar. 2025 was $-8.69 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was $-32.46 Mil.

Alpha Tau Medical Net Income From Continuing Operations Historical Data

The historical data trend for Alpha Tau Medical's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical Net Income From Continuing Operations Chart

Alpha Tau Medical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

-8.88

-27.27

-33.76

-29.16

-31.75

Alpha Tau Medical Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial														-7.98	-7.37	-6.92	-9.48	-8.69

Alpha Tau Medical Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-32.46 Mil.

Alpha Tau Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiryat Hamada Street 5, Jerusalem, ISR, 9777605

Website

https://www.alphatau.com

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.